FRAS1 antibody (PE)
-
- Target See all FRAS1 Antibodies
- FRAS1 (Fraser Syndrome 1 (FRAS1))
- Reactivity
- Human, Mouse, Rat
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This FRAS1 antibody is conjugated to PE
-
Application
- Flow Cytometry (FACS)
- Purification
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human FRAS1
- Isotype
- IgG
- Top Product
- Discover our top product FRAS1 Primary Antibody
-
-
- Application Notes
- FCM(1:20-100)
- Comment
-
Exitation/Emission: 480,565nm/578nm
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at 4°C
- Expiry Date
- 12 months
-
- Target
- FRAS1 (Fraser Syndrome 1 (FRAS1))
- Alternative Name
- Fras1 (FRAS1 Products)
- Background
-
This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can include craniofacial, urogenital and respiratory system abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009].
Subcellular location: Extracellular
Synonyms: Extracellular matrix protein FRAS1, Fras 1, Fras1, FRAS1_HUMAN, Fraser syndrome 1.
-